Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
- 30 April 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Pharmacotherapy
- Vol. 7 (3), 242-250
- https://doi.org/10.1093/ehjcvp/pvaa040
Abstract
Aortic valve stenosis (AS) is the third most common cardiovascular disease. The prevalence of both AS and arterial hypertension increases with age, and the conditions therefore often co-exist. Co-existence of AS and arterial hypertension is associated with higher global left ventricular (LV) pressure overload, more abnormal LV geometry and function, and more adverse cardiovascular outcome. Arterial hypertension may also influence grading of AS, leading to underestimation of the true AS severity. Current guidelines suggest re-assessing patients once arterial hypertension is controlled. Management of arterial hypertension in AS has historically been associated with prudence and concerns, mainly related to potential adverse consequences of drug-induced peripheral vasodilatation combined with reduced stroke volume due to the fixed LV outflow obstruction. Current evidence suggests that patients should be treated with antihypertensive drugs blocking the renin–angiotensin–aldosterone system, adding further drug classes when required, to achieve similar target blood pressure (BP) values as in hypertensive patients without AS. The introduction of transcatheter aortic valve implantation has revolutionized the management of patients with AS, but requires proper BP management during and following valve replacement. The purpose of this document is to review the recent evidence and provide practical expert advice on management of hypertension in patients with AS.Keywords
This publication has 87 references indexed in Scilit:
- Global left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial)Cardiovascular Ultrasound, 2012
- The evolving epidemiology of valvular aortic stenosis. The Tromsø StudyHeart, 2012
- Impact of Renin-Angiotensin System Blockade Therapy on Outcome in Aortic StenosisJournal of the American College of Cardiology, 2011
- Metabolic Syndrome Is Associated With More Pronounced Impairment of Left Ventricle Geometry and Function in Patients With Calcific Aortic Stenosis: A Substudy of the ASTRONOMER (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin)Journal of the American College of Cardiology, 2010
- Myocardial deformation in aortic valve stenosis: relation to left ventricular geometryHeart, 2009
- Paradoxical Low-Flow, Low-Gradient Severe Aortic Stenosis Despite Preserved Ejection Fraction Is Associated With Higher Afterload and Reduced SurvivalCirculation, 2007
- Impact of blood pressure on the Doppler echocardiographic assessment of severity of aortic stenosisHeart, 2006
- Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: symptomatic cardiac obstruction–pilot study of enalapril in aortic stenosis (SCOPE-AS)American Heart Journal, 2004
- Symptomatic Aortic StenosisHypertension, 2003
- Clinical Factors Associated With Calcific Aortic Valve DiseaseJournal of the American College of Cardiology, 1997